Utah
421 Wakara Way
Suite 309
Salt Lake City, UT 84108
New York
101 Avenue of the Americas, Suite 324
New York, NY 10013
Corporate Offices
New York
1460 Broadway
New York, NY 10036
Utah
421 Wakara Way
Suite 309
Salt Lake City, UT 84108
Renalytix AI PLC
Registered Office
Avon House
19 Stanwell Road
Penarth,
Cardiff, United Kingdom
Company Secretary: Salim Hamir
Enquiries
Renalytix AI
Media Enquiries
Sara Kienke
Tel: 801-447-2698
media@renalytixai.com
Walbrook PR Ltd
Media and Investor Relations
Tel: +44 (0)20 7933 8790
renalytix@walbrookpr.com
Latest News
03Aug
KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients
Surge in Chronic Kidney Disease and Kidney Failure Expected Post-COVID-19
Mount Sinai-Led Study to Assess 4,000 Surviving COVID-19 Patients.. Read More →
31Jul
Total Voting Rights
As of 31 July 2020, the Company's issued and fully paid share capital consists of 72,029,634 ordinary shares with a nominal value of £0.0025 each,.. Read More →
27Jul
Over allotment option exercise raises an additional US$10.9m
Renalytix AI plc announces that the underwriters of its global offering of new ordinary shares.. Read More →